ncRNA name
hsa-miR-1236-3p
Specific or universal ncRNAs
Specific ncRNAs
Class
MicroRNA
Biomarker
No
Biomarker application
Upstream regulatory factors
Not available
Downstream target
TPT1
Cancer name
Lung Cancer
Cancer site
Lung
Treatment type
Chemotherapy
Drug
Cisplatin
Impact of wild-type ncRNA on chemotherapy resistance
Down
Impact of knockdown of ncRNA on chemotherapy resistance
Impact of overexpression of ncRNA on chemotherapy resistance
ncRNA differential expression in
cancer
patients vs. healthy people
Down
Number of patients
Not available
Male patients
Not available
Female patients
Not available
Age range and number
Not available
PMID
Description
MiR-1236-3p could reverse DDP resistance by modulation of TPT1 gene and inhibition of Pim-3 signaling pathway in lung cancer cells.
Tissue resource
pairs of lung cancer tumor tissues and non-tumor adjacent tissues
human normal lung epithelial cell lines BESA-2B
lung cancer cell lines A549
Experiment
qRT-PCR,Luciferase reporter assay
Institute
Weifang Traditional Chinese Hospital
the Cell Bank of the Chinese Academy of Sciences
Country
China
Continent
Asia